To explore the association between GDI2 expression with 11 kinds of clinicopathologic characteristics, GDI2 expression was firstly classified into high- and low-level, and Chi-square test was applied to explore the difference between high and low expression of GDI2 in different clinicopathological characteristics of HCC patients (Table 1). This evidence concerns the gene GDI2 and hepatocellular carcinoma.